enVVeno Competitors and Similar CompaniesClear all
enVVeno's competitors and similar companies include Kymab and Neofluidics.
 enVVeno Envveno Medical (formerly known as Hancock Jaffe) is a company developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). |  Kymab Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics. | ||
Founding Date | Founding Date 1987 | Founding Date 2009 | Founding Date 2014 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Irvine, US HQ | Locations Cambridge, GB HQ | Locations San Diego, US HQ Lubbock, US |
Employees | Employees 1525% increase | Employees 407% decrease | Employees 3 |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 100m (over 9 years ago) | Latest funding round $ 175k (over 8 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 220.4m | Total funding raised $ 3.2m |
For sources of this data, please see the company profile
View Company Profiles
Kymab
HQ
Cambridge, GB
Employees
40↓ 7% decrease
Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics.
View company
Neofluidics
HQ
San Diego, US
Employees
3
Neofluidics is a company that develops tools and technology for enhanced microfluidics.
View company